Clinical Trials Logo

Clinical Trial Summary

Alvimopan is the first and currently the only FDA-approved therapy for acceleration of the time to upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis.

The primary objective of this retrospective observational trial is to assess postoperative morbidity and mortality as reported during the index hospitalization for bowel resection and 15/30-day readmissions of alvimopan vs. non-alvimopan matched patients in the combined Premier/Care Science database(a large medical claims database).


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01150760
Study type Observational
Source Cubist Pharmaceuticals LLC
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date August 2010

See also
  Status Clinical Trial Phase
Terminated NCT00065234 - Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus) Phase 2
Completed NCT01156129 - Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery Phase 1
Recruiting NCT05712525 - Gut Recovery In Patients Following Surgery
Completed NCT06338813 - Digital Manometry for Intra-Abdominal Pressure Measurement in Ileus N/A
Recruiting NCT05315765 - Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
Completed NCT02161367 - Effect of Simethicone on Postoperative Ileus in Patients Undergoing Colorectal Surgery Phase 4
Completed NCT03711487 - The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection Phase 2
Completed NCT00528970 - A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair Phase 3
Not yet recruiting NCT04001985 - Nasogastric Tube Clamping Trial vs. Immediate Removal N/A
Completed NCT02836470 - A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection Phase 2
Completed NCT04100447 - A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection Phase 1
Active, not recruiting NCT03795467 - Peripheral Perfusion Index, Haemoglobin and Blood Transfusion in Acute Surgical Patients
Completed NCT01143259 - Intermountain Healthcare's Enhanced Recovery Protocol for Colon Surgery With and Without Alvimopan Use N/A
Terminated NCT03352414 - Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC Phase 2
Not yet recruiting NCT04305730 - Use of Pedometer Following Radical Cystectomy N/A
Completed NCT02760290 - Comparison of Extraperitoneal and Intraperitoneal Cesarean Technique N/A
Active, not recruiting NCT02399605 - Subcutaneous Electrical Stimulation in the Prevention of Postoperative Ileus N/A
Completed NCT00388258 - Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Phase 3
Terminated NCT05470387 - A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection Phase 3
Completed NCT00205842 - Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Phase 3